You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ULTRAVIST 240 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ultravist 240 patents expire, and what generic alternatives are available?

Ultravist 240 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in ULTRAVIST 240 is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.

Drug patent expirations by year for ULTRAVIST 240
Recent Clinical Trials for ULTRAVIST 240

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BayerPhase 4
Guerbet/Liebel-FlarsheimPhase 4
Duke Clinical Research InstitutePhase 4

See all ULTRAVIST 240 clinical trials

Pharmacology for ULTRAVIST 240

US Patents and Regulatory Information for ULTRAVIST 240

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ULTRAVIST 240 iopromide INJECTABLE;INJECTION 020220-003 May 10, 1995 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ULTRAVIST 240

See the table below for patents covering ULTRAVIST 240 around the world.

Country Patent Number Title Estimated Expiration
Japan S55153755 TRIIODOISOPHTHALIC ACID DIAMIDE DERIVATIVE* ITS MANUFACTURE AND X RAY CONTRAST AGENT CONTAINING IT ⤷  Try a Trial
Mexico 9203691 NUEVOS MEDIOS DE CONTRASTE DE RAYOS X NO IONICOS. ⤷  Try a Trial
Greece 66668 ⤷  Try a Trial
Ireland 800467 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.